<DOC>
	<DOCNO>NCT01471132</DOCNO>
	<brief_summary>The recurrence metastasis peritoneum always lethal consequence gastric cancer patient , effective therapy . It report Dr.Fujimoto intraperitoneal chemotherapy plus hyperthermic therapy , call hyperthermic intraperitoneal chemotherapy ( HIPEC ) , eliminate suppress free cancer cell tiny metastasis abdomen . Refer experience systematic chemotherapy , HIPEC combination regimen would brighter prospect . In study , investigator would use Oxaliplatin paclitaxel sequent HIPEC regimen . The safety overall survival would observe evaluate .</brief_summary>
	<brief_title>Sequential HIPEC Oxaliplatin Paclitaxel Gastric Cancer Patients With Peritoneum Metastasis</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Histologically prove gastric adenocarcinoma . Peritoneum metastasis observe suspected laparoscopy radiologic examination , free cancer cell detect peritoneal lavage liquid . Potentially resectable gastric cancer . ALT , AST &lt; 80U/L ; Total Bilirubin &lt; 30Î¼mol/L ; WBC &gt; 4x10^9/L ; PLT &gt; 100x10^9/L ; Cr &lt; 1.5 fold normal value . ECOG 02 point . Expected survival time longer 3 month . Informed consent . Recurrent gastric cancer . Pregnant lactating woman . Allergic oxaliplatin paclitaxel . Abnormal liver/kidney function . Serious heart/metabolic disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>